Tissue and cell-type specific expression of the tuberous sclerosis gene, TSC2, in human tissues

Modern Pathology

Volumn 9, Issue 11, 1996, Pages 1071-1080

  Menchine, Michael ^a   Emelin, Jessica K ^a   Mischel, Paul S ^a   Haag, Thomas A ^a   Norman, Margaret G ^b   Pepkowitz, Samuel H ^c   Welsh, Cynthia T ^a   Townsend, Jeannette J ^d   Vinters, Harry V ^a,e  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cortical dysplasia; Epilepsy; Genes; Mental retardation; Phakomatosis; Tuberin; Tuberous sclerosis

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NEWBORN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TISSUE DISTRIBUTION; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR GENE;

ADULT; BRAIN; CHILD; CHILD, PRESCHOOL; DNA PRIMERS; DNA PROBES; ENDOCRINE GLANDS; EPITHELIUM; FEMALE; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; IN SITU HYBRIDIZATION; INFANT; INFANT, NEWBORN; LYMPHOCYTES; MALE; MIDDLE AGED; PREGNANCY; REPRESSOR PROTEINS; RNA, MESSENGER; TISSUE DISTRIBUTION; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 0029826140     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Stefansson K: Tuberous sclerosis. Mayo Clin Proc 66:868, 1991
2. Cares RM: The tuberous sclerosis complex. J Neuropathol Exp Neurol 17:247, 1958
3. Kwiatkowski DJ, Short MP: Tuberous sclerosis. Arch Dermatol 130:348, 1994
4. Gomez MR: Tuberous Sclerosis, Ed 2. New York, Raven Press, 1988
5. Nakamura Y, Becker LE: Subependymal giant-cell tumor: Astrocytic or neuronal? Acta Neuropathol 60:271, 1983
6. Critchley M, Earl CJC: Tuberose sclerosis and allied conditions. Brain 55:311, 1932
7. Richardson EP Jr: Pathology of tuberous sclerosis. Neuropathologic aspects. Ann N Y Acad Sci 615:128, 1991
8. Osborne JP, Fryer A, Webb D: Epidemiology of tuberous sclerosis. Ann N Y Acad Sci 615:125, 1991
9. Stefansson K, Wollmann R: Distribution of glial fibrillary acidic protein in central nervous system lesions of tuberous sclerosis. Acta Neuropathol 52:135, 1980
10. Ilgren EB, Westmoreland D: Tuberous sclerosis: Unusual associations in four cases. J Clin Pathol 37:272, 1984
11. Webb DW, Osborne JP: New research in tuberous sclerosis. BMJ 304:1647, 1992
12. Harris RM, Carter NP, Griffiths B, et al.: Physical mapping within the tuberous sclerosis linkage group in region 9q32-q34. Genomics 15:265, 1993
13. Haines JL, Short MP, Kwiatkowski DJ, et al.: Localization of one gene for tuberous sclerosis within 9q32-34, and further evidence for heterogeneity. Am J Hum Genet 49: 764, 1991
14. The European Chromosome 16 Tuberous Sclerosis Consortium: Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305, 1993
15. Green AJ, Johnson PH, Yates JRW: The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum Mol Genet 3:1833, 1994
16. Povey S, Burley MW, Attwood J, et al.: Two loci for tuberous sclerosis: One on 9q34 and one on 16p13. Ann Hum Genet 58:107, 1994
17. Sampson JR, Harris PC: The molecular genetics of tuberous sclerosis. Hum Mol Genet 3:1477, 1994
18. Janssen B, Sampson J, van der Est M, et al.: Refined localization of TSC1 by combined analysis of 9q34 and 16p13 data in 14 tuberous sclerosis families. Hum Genet 94:437, 1994
19. Menchine M, Mischel PS, Jimenez J, Vinters HV: TSC2 mRNA is a developmentally regulated pyramidal cell marker which is overexpressed in cytomegalic neurons of tuberous sclerosis, cortical dysplasia, and ganglioglioma (abstract). J Neuropathol Exp Neurol 54:413, 1995
20. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294, 1979
21. Lion T, Haas OA: Nonradioactive labeling of probe with digoxigenin by polymerase chain reaction. Anal Biochem 188:335, 1990
22. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, Ed 2. Cold Spring Harbor, NY, CSH Laboratory Press, 1989
23. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74: 5463, 1977
24. Bassam BJ, Caetano-Anollés G, Gresshoff PM: Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem 196:80, 1991
25. De Rosa MJ, Secor DL, Barsom M, Fisher RS, Vinters HV: Neuropathologic findings in surgically treated hemimegalencephaly: Immunohistochemical, morphometric, and ultrastructural study. Acta Neuropathol 84:250, 1992
26. Landwehrmeyer GB, McNeil SM, Dure LS IV, et al.: Huntington's disease gene: Regional and cellular expression in brain of normal and affected individuals. Ann Neurol 37:218, 1995
27. Kleiner DE, Emmert-Buck MR, Liotta LA: Necropsy as a research method in the age of molecular pathology. Lancet 346:945, 1995
28. Palmini A, Andermann F, Olivier A, et al.: Focal neuronal migration disorders and intractable partial epilepsy: A study of 30 patients. Ann Neurol 30:741, 1991
29. Farrell MA, DeRosa MJ, Curran JG, et al.: Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy. Acta Neuropathol 83:246, 1992
30. Jay V, Becker LE: Surgical pathology of epilepsy: A review. Pediatr Pathol 14:731, 1994
31. Mischel PS, Nguyen LP, Vinters HV: Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 54:137, 1995
32. Kerfoot C, Wienecke R, Menchine M, et al.: Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis. Brain Pathol 6:367, 1996
33. Wienecke R, König A, DeClue JE: Identification of tuberin, the tuberous sclerosis-2 product. J Biol Chem 270:16409, 1995
34. Carbonara C, Longa L, Grosso E, et al.: 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. Hum Mol Genet 3:1829, 1994
35. Green AJ, Smith M, Yates JRW: Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet 6:193, 1994
36. Henske EP, Scheithauer BW, Short MP, et al.: Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet 59:400, 1996
37. Gomez MR: Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria. Ann N Y Acad Sci 615:1, 1991
38. Geist RT, Gutmann DH: The tuberous sclerosis 2 gene is expressed at high levels in the cerebellum and developing spinal cord. Cell Growth Differ 6:1477, 1995
39. Gilman AG: G proteins: Transducers of receptor-generated signals. Annu Rev Biochem 56:615, 1987
40. Knudson AG: Antioncogenes and human cancer. Proc Natl Acad Sci U S A 90:10914, 1993
41. Levine AJ: The tumor suppressor genes. Annu Rev Biochem 62:623, 1993
42. Farrell MA, Green AJ, Sepp T, Mischel P, Vinters HV: Loss of heterozygosity in sporadic cortical dysplasia for DNA markers in the region of the tuberous sclerosis (TSC1) gene on chromosome 9q34 (abstract). J Neuropathol Exp Neurol 54: 414, 1995
43. Knudson AG Jr: Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68:820, 1971
44. Smalley SL, Burger F, Smith M: Phenotypic variation of tuberous sclerosis in a single extended kindred. J Med Genet 31:761, 1994
45. Northrup H, Wheless JW, Bertin TK, Lewis RA: Variability of expression in tuberous sclerosis. J Med Genet 30:41, 1993
46. Haines JL, Amos J, Attwood J, et al.: Genetic heterogeneity in tuberous sclerosis. Study of a large collaborative dataset. Ann N Y Acad Sci 615:256, 1991